PharmExec

DECEMBER 20, 2023

This podcast addresses critical topics such as cybersecurity, regulatory compliance and fiscal strategy for pharmaceutical labs and offers valuable insights for professionals at the crossroads of technology, finance, and pharmaceutical regulations.

52

52

PharmExec

DECEMBER 20, 2023

This podcast addresses critical topics such as cybersecurity, regulatory compliance and fiscal strategy for pharmaceutical labs and offers valuable insights for professionals at the crossroads of technology, finance, and pharmaceutical regulations.

52

52

Pharma Marketing Network

JULY 19, 2023

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry Content marketing is a long-term strategy that can help businesses of all sizes generate leads, increase brand awareness, and drive sales.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

Express Pharma

JANUARY 15, 2024

Each year, we evaluate around 100 applications, including reviewing technical essays on various topics such as post-pandemic pharmacy or digitalisation and artificial intelligence in the pharmaceutical industry and conducting 1-to-1 interviews.

Packaging 103

Packaging 103

PharmaState Academy

MARCH 6, 2024

CASE STUDY Building Trust in Cross-Cultural Sales Interactions Enhancing Interpersonal Skills in Pharmaceutical Sales Table of Contents Case Study Introduction: In the dynamic landscape of pharmaceutical sales, expanding into new regions with diverse cultural backgrounds presents both opportunities and challenges.

Communication 52

Communication Documentation 52

Pharmaceutical Business Review

MARCH 5, 2024

This marks a significant advancement in ophthalmic care, introducing the first FDA-approved ophthalmic formulation of clobetasol propionate, a corticosteroid and the first new steroid in the ophthalmic market in over one and half decades.

59

59

PharmaState Academy

JANUARY 23, 2024

The event, featuring keynote speeches, presentations, and dynamic discussions, explored critical topics such as brand management, corporate branding, pharmaceutical innovations, and global brand management challenges and strategies for Bangladesh Pharma Industry.

Biosimilars 52

Biosimilars Communication 52

PharmaState Academy

MARCH 4, 2024

However, you caution the team against complacency, reminding them that success during peak sales periods isn’t just about working harder—it’s about working smarter. Read the whole case study scenario Close Brainstorming Question Which of the following is a key consideration when balancing workload during peak sales periods?

Communication 52

Communication 52

Definitive Healthcare

AUGUST 8, 2022

Resource Type Whitepapers & Research Marketo form number 1747 Case Study Buyer's Guide Whitepaper Transforming a sales team with data-driven market intelligence from Definitive … Healthcare data & analytics buying guide for medical device firms Shifting point of care to ambulatory surgery centers Image Image Image ","nextArrow":" ","appendArrows":".coh-slider-nav-bottom","dots":false,"draggable":true,"swipe":true,"fade":false,"vertical":false,"speed":700,"cssEase":"ease","pauseOnHo

52

52

Express Pharma

OCTOBER 18, 2023

To showcase new technologies and solutions for the Indian market, B&R Industrial Automation recently organised Innovations Day on August 31, 2023, in Pune to experience the future of automation with ground-breaking innovations, especially for machine builders, system integrators and end users.

Packaging 87

Packaging 87

Pharmaceutical Technology

DECEMBER 5, 2022

Incyte has signed a partnership and licence agreement with CMS subsidiary CMS Aesthetics to develop and market ruxolitinib cream to treat autoimmune and inflammatory dermatologic ailments in Greater China and some Southeast Asian countries. Incyte will also receive royalty payments on the net product sales in the territory of CMS.

52

52

pharmaphorum

DECEMBER 29, 2021

IL-13 inhibitor tralokinumab has been cleared by the US regulator as Adbry as a treatment for moderate-to-severe atopic dermatitis in adults who can’t control symptoms using topical prescription therapies. It continues to grow strongly with Sanofi reporting a 53% rise in sales to more than $4.1 billion in the same year.

Labelling 109

Labelling 109

PharmaState Academy

FEBRUARY 3, 2024

Brands that become synonyms of the generic drug and brands that ride at the crest of the ever-evolving market landscape. All pharma marketing professionals. Students Management Trainees Product Executives Product Managers Group Product Managers Marketing Heads Why should you attend? Brands that have a positive impact on society.

Communication 59

Communication 59

Pharmaceutical Technology

OCTOBER 31, 2022

The osteoarthritis (OA) market was valued at $2.5 billion in the 7MM (seven major markets) in 2021, and is expected to increase to $3.8 These are forecast to contribute significantly towards sales in the OA market in 2031, accounting for 10% and 14.2% of the 7MM sales, respectively. in the US).

Compounding 59

Compounding Pharmaceutical Companies Pharmaceutical Companies 59

Pharma Marketing Network

NOVEMBER 6, 2020

The Pharma Marketing Wire is the bi-monthly e-newsletter of the Pharma Marketing Network® (PMN), which features original articles from pharmaceutical marketing experts and industry executives. Please email us a topic/topics you wish to submit an article about to publisher@pharma-mkting.com. Physician marketing.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies 40

Viseven

MAY 15, 2023

Pharmaceutical detailing is the most time-tested marketing format in the medical content world. Old-timer sales reps should remember how pharmaceutical companies reckoned face-to-face (F2F) visits with doctors as the most effective approach to achieving their sales targets. What is Pharmaceutical Detailing?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

epicur

OCTOBER 27, 2023

You may have already met our newest team member at a trade show or heard from him in sales meetings – we’re excited to introduce Nick Cagliostro, National Sales Manager! We sat down with Nick to learn more about his work in veterinary sales and the changes he’s most excited about for Epicur.

Hospitals 52

Hospitals Compounding Compounding Pharmacies 52

Pharmaceutical Technology

AUGUST 28, 2022

In the 92 low- and middle-income countries in the GAVI COVAX Advance Market Commitment (AMC 92), the company said it will not impose its patents on any Covid-19 vaccines. It has no plans to seek removal of Comirnaty from the market and will not seek an injunction to stop its sale in the future.

Vaccines 98

Vaccines 98

PharmaState Academy

NOVEMBER 8, 2023

This is "not to be missed" Masterclass for Pharma Marketers! ???????????: Although RWE is a powerful tool for pharma marketing, however many pharma marketers don’t know exactly what RWE is. To be awarded with 3CPhE (Continuing Pharma Education) points. Who should attend? Educator Rating 4.8/5

Communication 105

Communication 105

Pharmaceutical Technology

DECEMBER 8, 2022

According to the revised deal, Daiichi Sankyo and Kite will transfer the Marketing Authorization for Yescarta to Gilead’s Japan subsidiary, Gilead Sciences K.K., The therapy’s sales and promotion works in Japan following the transfer of marketing authorisation will be carried out by the Kite Cell Therapy Business Unit at Gilead Sciences K.K.

Communication 122

Communication Immunity Immunization Hospitals 122

Pharmaceutical Technology

MAY 10, 2023

While the government said that Gilead secured its PrEP approvals only after CDC’s research on the topic, the company stated that there already were published materials on the potential use of antiretroviral therapies as PrEP prior to this. Gilead markets both Truvada and its successor Descovy.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

Digital Pharmacist

JANUARY 16, 2023

Creating a 2023 health awareness calendar this year is a great way to market your pharmacy while promoting patient health. . They’re also a great addition to your pharmacy’s marketing strategy, allowing you to develop relationships with your audience while advertising relevant products and services. Not feeling well-rested?

Immunity 98

Immunity Immunization Vaccines Diabetes 98

Pharmaceutical Technology

AUGUST 4, 2022

According to the deal, Poseida will offer either exclusive rights or options to Roche for developing and marketing various allogeneic CAR-T programmes in its portfolio targeting hematologic malignancies. Furthermore, Roche will oversee the late-stage clinical development and worldwide marketing of all products under the alliance.

59

59

pharmaphorum

APRIL 30, 2021

It’s fair to say this is the most interesting time ever for market access. We take a look at all these intersecting topics in this issue – with experts from across the industry sharing their advice on how companies can navigate these paradigm shifts. Time for a NICE change. How will NICE fare in a post-Brexit world?

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

Pharmaceutical Technology

DECEMBER 23, 2022

Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. Topic sponsors are not involved in the creation of editorial content. The companies entered the initial agreement in September last year. Free Whitepaper.

Diabetes 131

Diabetes Communication 131

Viseven

JULY 26, 2023

Collision is one of the world’s biggest tech conferences where businesses, leaders, investors, designers, developers, marketers, media, innovation enthusiasts, and artificial intelligence (AI) evangelists engage with each other, share knowledge, and learn how technology is transforming global business. The event’s schedule was massive.

Communication 52

Communication 52

pharmaphorum

FEBRUARY 28, 2022

Amryt Pharma has been handed a major blow by the FDA, after the US regulator rejected its marketing application for Oleogel-S10, its drug for rare and debilitating skin disease epidermolysis bullosa (EB). Read Faith’s story and more personal stories at [link] & share them on your social media to help raise awareness!

98

98

Pharmaceutical Technology

DECEMBER 14, 2022

Additionally, for WVE-006, GSK will make development and launch milestone payments of up to $225m to Wave, which is also eligible to get up to $300m in milestone payments based on sales. On completion of the first-in-patient clinical trial by Wave, GSK will be in charge of the development and marketing works. Free Whitepaper.

Communication 64

Communication 64

PharmaState Academy

JANUARY 23, 2024

The focus was on the marketing and promotion of pharmaceutical brands, featuring experienced speakers who shared valuable insights and experiences. He emphasized the importance of ethical marketing in the pharmaceutical industry and drew distinctions between products and brands.

Communication 52

Communication Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

MAY 31, 2022

At the moment, treatment typically involves oral or topical corticosteroids, antihistamines and some antidepressant drugs, but responses are often inadequate, vary widely between patients, and come with the burden of safety risks if used long-term. billion) a year and some analysts predicting levels could go as high as $12.5

113

113

Viseven

JUNE 12, 2023

The global pharmaceutical market is becoming more digitalized, insight-driven, and consumer-centric. In this article, we’ll focus on a pharmaceutical market in the APAC region, go through the differences between pharma in APAC and pharma in other parts of the world, and see the current state of the APAC pharma market.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 52

PharmaShots

JANUARY 23, 2023

Until recently, there were very few topical options available for treating plaque psoriasis long-term. Typically, some patients start with topical steroids; however, these can be challenging, as many are limited by where they can be applied on the body and for how long and how often they can be used. [i] of VTAMA cream?

Labelling 40

Labelling Immunity Immunization 40

pharmaphorum

MAY 25, 2022

Vtama (tapinarof) – originally developed by GlaxoSmithKline – is a first-in-class, once-daily topical therapeutic aryl hydrocarbon receptor modulating agent (TAMA) and has been approved by the US regulator with a broad label spanning mild, moderate, and severe psoriasis and an unlimited duration of use. Otezla – which Amgen acquired for $13.4

Labelling 52

Labelling Biosimilars 52

Viseven

OCTOBER 3, 2023

Viseven and Veeva have been partners for many years, providing advanced technology and content expertise to pharma and life sciences businesses and agencies of all sizes, and it was a big honor and privilege for the Viseven team to be at the event and make its own contribution to the evolution of biopharma digital marketing.

52

52

pharmaphorum

OCTOBER 28, 2022

In 2018, she was nominated by Pharmaceutical Marketing Europe as one of the 30 most influential women in UK Healthcare, and in September 2019 appointed by the UK’s Chief Scientific Officer to be an Ambassador for Women in Science and Engineering (WISE). She is an SME in market access, rare disease and biosimilars.

Biosimilars 120

Biosimilars 120

Pharmaceutical Technology

DECEMBER 12, 2022

The development, clinical trial and marketing expenses for the cell therapy will be shared by the companies while co-commercialising the product and equally splitting profits from the US region. Kite will oversee the marketing of the product outside the US while Arcellx is eligible for royalty payments on sales. Free Whitepaper.

Communication 105

Communication 105

Pharmaceutical Technology

MAY 16, 2023

This comes with an upfront cash payment of $375 million, with a potential additional $25 million if Hemgenix net sales reach a certain milestone in 2024, based on a May 15 announcement. Additionally, UniQure was set to get tiered royalties of up to “a low-twenties percentage” of net product sales related to Hemgenix.

52

52